Skip to content

Analgesic Effect of Oral Glucose in Neonates

Efficacy of Oral Glucose in Pain Alleviation Among Healthy Term Neonates Undergoing Circumcision

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04467177
Enrollment
60
Registered
2020-07-10
Start date
2020-07-01
Completion date
2021-06-30
Last updated
2020-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Background: Male circumcision is one of the oldest and most common operations performed all over the world. It can be performed at different ages, using different surgical techniques, for different religious, cultural and medical reasons. It was thought that the newborn baby does not experience pain because of incompletely developed nervous system. However, it has been shown that neurological system known to be associated with pain transmission and modulation, is intact and functional. OBJECTIVE: Our objective is to determine if a 30% glucose solution would reduce pain after circumcision compared with normal saline. STUDY DESIGN: This is a randomized placebo-controlled double-blinded clinical trial. POPULATION: We will include full term neonates, who will be recruited from the inpatient nursery at Makassed General Hospital over a 1-year period. OUTCOME MEASURE: The primary outcome is to assess efficacy of 30% glucose on pain measured using the Neonatal Infant Pain Score. Secondary outcome is to assess effect of 30% glucose oh physiologic parameters

Interventions

Male neonates will receive 2 ml of 30% glucose two minutes prior to circumcision

OTHERPlacebo

Male neonates will receive 2 ml of sterile water two minutes prior to circumcision

Sponsors

Makassed General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
1 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Estimated gestational age: 37 weeks-42 weeks * Birth weight: 2500 grams-4000 grams * Apgar scores a minimum of 7 at 1 and 5 minutes respectively * Heart rate between 100 and 160 per minutes * Blood O2 saturation of at least 95% * No recognized congenital abnormalities

Exclusion criteria

* They were transferred to the neonatal intensive care unit (NICU) * They required respiratory support

Design outcomes

Primary

MeasureTime frameDescription
Pain scorePain will be assessed 1 minute before the procedure and during the procedurePain response will be assessed utilizing the Neonatal Infant Pain Scale. The total pain score ranges from 0 to 10. Scores less than or equal to 3 indicate no pain while scores greater than 3 indicate pain.

Secondary

MeasureTime frameDescription
Heart rate2 minutes before the procedure, during the procedure and one minute after the procedureHeart rate (beats per minute) will be recorded
Respiratory rate2 minutes before the procedure, during the procedure and one minute after the procedureRespiratory rate (breaths per minute) will be recorded
Oxygen saturation2 minutes before the procedure, during the procedure and one minute after the procedureOxygen saturation (in percent) will be recorded

Countries

Lebanon

Contacts

Primary ContactAmal Naous, MD
amalnaous@hotmail.com+9611636000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026